Xenon Pharmaceuticals Inc. 4
4 · Xenon Pharmaceuticals Inc. · Filed May 4, 2015
Insider Transaction Report
Form 4
STEIN EVAN A.
Director
Transactions
- Other
Common Shares
2015-04-30−1,038,964→ 0 total(indirect: See Footnote) - Other
Common Shares
2015-04-30+4,172→ 4,172 total(indirect: See Footnote) - Other
Common Shares
2015-04-30+909,619→ 910,586 total(indirect: See Footnote)
Footnotes (6)
- [F1]In kind pro-rata distribution from Lipoterx, Ltd. to its partners, without consideration.
- [F2]These shares were held by Lipoterx, Ltd. Lipoterx Holdings, LLC ("Lipoterx Holdings"), the general partner of Lipoterx, Ltd., had sole voting and investment power with respect to the shares held by Lipoterx, Ltd. The Reporting Person, the managing partner of Lipoterx Holdings, had sole voting and investment power with respect to the shares held by Lipoterx, Ltd.
- [F3]Acquisition by the Stein Family LLC, pursuant to an in kind pro-rata distribution by Lipoterx, Ltd. to its partners, without consideration.
- [F4]These shares are held by the Stein Family LLC, for which the Reporting Person serves as the managing member.
- [F5]Acquisition by Lipoterx Holdings, pursuant to an in kind pro-rata distribution by Lipoterx, Ltd. to its partners, without consideration.
- [F6]These shares are held by Lipoterx Holdings. The Reporting Person, the managing partner of Lipoterx Holdings has sole voting and investment power with respect to the shares held.